ADVISORY BOARD

Dr Richard C Boucher MD

Dr Richard C Boucher MD

Professor Boucher is currently the James Moeser Eminent Professor of Medicine and Director of the Marsico Lung Institute and the University of North Carolina CF Centre at Chapel Hill. More...

Dr Jane Davies MB Chb

Dr Jane Davies MB Chb

Professor Davies is Professor of Paediatric Respirology & Experimental Medicine at the National Heart and Lung Institute (NHLI) More...

Dr Luis Galietta, PhD

Dr Luis Galietta, PhD

Professor Galietta is a group leader of the Molecular Genetics Laboratory at the Institute Giannina Gaslini, in Genoa, Italy. More...

Dr Wisia Wedzicha MB, FMedSci

Dr Wisia Wedzicha MB, FMedSci

Professor Wedzicha is Professor of Respiratory Medicine at the National Heart and Lung Institute, Imperial College, UK. More...

Dr Simon Ward, PhD

Dr Simon Ward, PhD

Professor Simon Ward is the Sêr Cymru Professor in Translational Drug Discovery and Director of the Medicines Discovery Institute at Cardiff University. More...

Enterprise is a biopharmaceutical company dedicated to the research and development of novel therapies for the treatment of respiratory diseases of high unmet medical need and commercial opportunity – the company plans to initiate clinical trials in 2019.

Scientific Strategy

Enterprise is developing muco-regulatory drugs that are expected to help respiratory patients by improving their ability to breath and reduce the number of lung infections they experience leading to a longer and more healthy life.

Learn more

Pipeline

Enterprise has developed a pipeline of novel low molecular weight compounds with first in class potential – our most advanced compounds, which target ion channels in the airway epithelium are expected to enter human trials in late 2019.

Learn more